Literature DB >> 7689157

Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.

M Sala-Trepat1, J Boyse, P Richard, D Papadopoulo, E Moustacchi.   

Abstract

The mutant frequency of 6-thioguanine resistance (HPRT locus) in circulating T lymphocytes from 23 Fanconi anemia (FA) patients has been determined. The glycophorin A (GPA) in vivo cell mutants assay, which detects allele loss variant phenotypes arising from mutations in erythroid progenitor cells of GPA heterozygous MN individuals, has been applied in parallel to FA patients. No significant difference in frequency of HPRT- mutants was observed in FA compared to age matched healthy donors. In contrast, the mean frequency of GPA variant cells was elevated 31-fold for hemizygous NO variants and 8-fold for homozygous NN variants in FA patients over normal controls. In heterozygous FA parents, HPRT- mutant frequencies and GPA variant frequencies were within the normal range. Molecular analysis of HPRT- mutants has previously shown that FA cells have a high tendency to form deletions. Knowing that the cellular events allowing the detection of mutations at the HPRT and the GPA locus differ, our results emphasize the possible correlation between events of spontaneous loss of heterozygosity and genetic predisposition to cancer as observed in FA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689157     DOI: 10.1016/0027-5107(93)90137-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.

Authors:  Lorri R Marek; Molly C Kottemann; Peter M Glazer; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2008-02-06

Review 2.  DNA interstrand crosslink repair and cancer.

Authors:  Andrew J Deans; Stephen C West
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

3.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.

Authors:  Koji Nakanishi; Yun-Gui Yang; Andrew J Pierce; Toshiyasu Taniguchi; Martin Digweed; Alan D D'Andrea; Zhao-Qi Wang; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-13       Impact factor: 11.205

4.  Sequence variation in the Fanconi anemia gene FAA.

Authors:  O Levran; T Erlich; N Magdalena; J J Gregory; S D Batish; P C Verlander; A D Auerbach
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination.

Authors:  A Laquerbe; E Moustacchi; J C Fuscoe; D Papadopoulo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

6.  Use of the glycophorin A somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype.

Authors:  Viktoria N Evdokimova; Reagan K McLoughlin; Sharon L Wenger; Stephen G Grant
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

7.  Analysis of genomic instability using multiple assays in a patient with Rothmund-Thomson syndrome.

Authors:  S G Grant; S L Wenger; J J Latimer; D Thull; L W Burke
Journal:  Clin Genet       Date:  2000-09       Impact factor: 4.438

8.  Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Authors:  Stephen G Grant; Rubina Das; Christina M Cerceo; Wendy S Rubinstein; Jean J Latimer
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

Review 9.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

10.  Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans.

Authors:  N Rothman; R Haas; R B Hayes; G L Li; J Wiemels; S Campleman; P J Quintana; L J Xi; M Dosemeci; N Titenko-Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.